Sorin J Brener

Summary

Affiliation: New York Presbyterian Hospital
Country: USA

Publications

  1. doi request reprint Complementary prognostic utility of myocardial blush grade and ST-segment resolution after primary percutaneous coronary intervention: analysis from the HORIZONS-AMI trial
    Sorin J Brener
    New York Methodist Hospital, Brooklyn, NY Cardiovascular Research Foundation, New York, NY Electronic address
    Am Heart J 166:676-83. 2013
  2. doi request reprint Everolimus-eluting stents in patients undergoing percutaneous coronary intervention: final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery
    Sorin J Brener
    NY Methodist Hospital and the Cardiovascular Research Foundation, New York, NY Electronic address
    Am Heart J 166:1035-42. 2013
  3. doi request reprint Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial
    Sorin J Brener
    Department of Medicine, New York Methodist Hospital, Brooklyn, New York 11215, USA
    JACC Cardiovasc Interv 6:718-24. 2013
  4. doi request reprint Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial
    Sorin J Brener
    New York Methodist Hospital, Brooklyn, NY, USA
    Am Heart J 166:64-70. 2013
  5. doi request reprint Intra-procedural stent thrombosis: a new risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndromes
    Sorin J Brener
    New York Methodist Hospital, Brooklyn, New York Cardiovascular Research Foundation, New York, NY 11215, USA
    JACC Cardiovasc Interv 6:36-43. 2013
  6. doi request reprint Does clinical presentation affect outcome among patients with acute coronary syndromes undergoing percutaneous coronary intervention? Insights from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree study
    Sorin J Brener
    New York Methodist Hospital, Brooklyn, NY, USA
    Am Heart J 164:561-7. 2012
  7. doi request reprint Operator versus core laboratory assessment of angiographic reperfusion markers in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction
    Sorin J Brener
    Cardiac Catheterization Laboratory, New York Methodist Hospital, 506 6th St, Brooklyn, NY 11215, USA
    Circ Cardiovasc Interv 5:563-9. 2012
  8. doi request reprint Risks and complications of coronary angiography: a comprehensive review
    Morteza Tavakol
    New York Methodist Hospital, NY, USA
    Glob J Health Sci 4:65-93. 2012
  9. doi request reprint Diabetes mellitus, myocardial reperfusion, and outcome in patients with acute ST-elevation myocardial infarction treated with primary angioplasty (from HORIZONS AMI)
    Sorin J Brener
    New York Methodist Hospital, Brooklyn, USA
    Am J Cardiol 109:1111-6. 2012
  10. doi request reprint Characteristics and clinical significance of angiographically mild lesions in acute coronary syndromes
    Sorin J Brener
    New York Methodist Hospital, Brooklyn, New York 11215, USA
    JACC Cardiovasc Imaging 5:S86-94. 2012

Detail Information

Publications52

  1. doi request reprint Complementary prognostic utility of myocardial blush grade and ST-segment resolution after primary percutaneous coronary intervention: analysis from the HORIZONS-AMI trial
    Sorin J Brener
    New York Methodist Hospital, Brooklyn, NY Cardiovascular Research Foundation, New York, NY Electronic address
    Am Heart J 166:676-83. 2013
    ..We sought to clarify how frequently MBG and STR provide discordant measures of reperfusion success and to determine the independent prognostic significance of each on long-term outcomes...
  2. doi request reprint Everolimus-eluting stents in patients undergoing percutaneous coronary intervention: final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery
    Sorin J Brener
    NY Methodist Hospital and the Cardiovascular Research Foundation, New York, NY Electronic address
    Am Heart J 166:1035-42. 2013
    ..We compared the outcomes of patients treated with everolimus-eluting stents (EES) versus paclitaxel-eluting stents (PES) at 3 years from the large-scale randomized SPIRIT IV trial...
  3. doi request reprint Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial
    Sorin J Brener
    Department of Medicine, New York Methodist Hospital, Brooklyn, New York 11215, USA
    JACC Cardiovasc Interv 6:718-24. 2013
    ....
  4. doi request reprint Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial
    Sorin J Brener
    New York Methodist Hospital, Brooklyn, NY, USA
    Am Heart J 166:64-70. 2013
    ..This study aimed to compare infarct size and clinical outcomes in patients with proximal versus mid left anterior descending (mLAD) infarction...
  5. doi request reprint Intra-procedural stent thrombosis: a new risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndromes
    Sorin J Brener
    New York Methodist Hospital, Brooklyn, New York Cardiovascular Research Foundation, New York, NY 11215, USA
    JACC Cardiovasc Interv 6:36-43. 2013
    ..The aim of this study was to examine the incidence, correlates, and consequences of intra-procedural stent thrombosis (IPST) in patients with acute coronary syndromes (ACS)...
  6. doi request reprint Does clinical presentation affect outcome among patients with acute coronary syndromes undergoing percutaneous coronary intervention? Insights from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree study
    Sorin J Brener
    New York Methodist Hospital, Brooklyn, NY, USA
    Am Heart J 164:561-7. 2012
    ..We compared the angiographic and intravascular ultrasound (IVUS) characteristics of patients with STEMI and NSTEMI in the PROSPECT study to evaluate the independent prognostic value of clinical presentation on long-term outcome...
  7. doi request reprint Operator versus core laboratory assessment of angiographic reperfusion markers in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction
    Sorin J Brener
    Cardiac Catheterization Laboratory, New York Methodist Hospital, 506 6th St, Brooklyn, NY 11215, USA
    Circ Cardiovasc Interv 5:563-9. 2012
    ....
  8. doi request reprint Risks and complications of coronary angiography: a comprehensive review
    Morteza Tavakol
    New York Methodist Hospital, NY, USA
    Glob J Health Sci 4:65-93. 2012
    ..In this review, we examine in detail the major complications associated with invasive cardiac procedures and provide the reader with a comprehensive bibliography for advanced reading...
  9. doi request reprint Diabetes mellitus, myocardial reperfusion, and outcome in patients with acute ST-elevation myocardial infarction treated with primary angioplasty (from HORIZONS AMI)
    Sorin J Brener
    New York Methodist Hospital, Brooklyn, USA
    Am J Cardiol 109:1111-6. 2012
    ..70). In conclusion, DM is associated with a significantly higher risk of death but this association is not mediated by impaired epicardial or myocardial reperfusion...
  10. doi request reprint Characteristics and clinical significance of angiographically mild lesions in acute coronary syndromes
    Sorin J Brener
    New York Methodist Hospital, Brooklyn, New York 11215, USA
    JACC Cardiovasc Imaging 5:S86-94. 2012
    ....
  11. doi request reprint Relationship between angiographic dynamic and densitometric assessment of myocardial reperfusion and survival in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: the harmonizing outcomes with revasculariza
    Sorin J Brener
    NY Methodist Hospital, Brooklyn, NY, USA
    Am Heart J 162:1044-51. 2011
    ..We evaluated 2 different methods of assessing tissue myocardial perfusion (TMP) and its impact on long-term mortality in patients with ST-segment elevation myocardial infarction (STEMI)...
  12. ncbi request reprint Relationship between the angiographically derived SYNTAX score and outcomes in high-risk patients undergoing percutaneous coronary intervention
    Sorin J Brener
    Cardiac Catheterization Laboratory, NY Methodist Hospital, 506 6th Street, KP 2, Brooklyn, NY 11215, USA
    J Invasive Cardiol 23:66-9. 2011
    ....
  13. doi request reprint The relationship between late lumen loss and restenosis among various drug-eluting stents: a systematic review and meta-regression analysis of randomized clinical trials
    Sorin J Brener
    Division of Cardiology, New York Methodist Hospital, Brooklyn, NY, USA
    Atherosclerosis 214:158-62. 2011
    ..To relate late lumen loss (LLL) after drug-eluting stent (DES) implantation to angiographic (BAR) and target vessel revascularization (TVR) in randomized clinical trials of DES...
  14. doi request reprint Precision and accuracy of risk scores for in-hospital death after percutaneous coronary intervention in the current era
    Sorin J Brener
    Division of Cardiology, Cardiac Catheterization Laboratory, NY Methodist Hospital, Brooklyn, New York 11215, USA
    Catheter Cardiovasc Interv 75:153-7. 2010
    ....
  15. ncbi request reprint Three-year survival after percutaneous coronary intervention according to appropriateness criteria for revascularization
    Sorin J Brener
    NY Methodist Hospital, Division of Cardiology, Brooklyn, NY 11215, USA
    J Invasive Cardiol 21:554-7. 2009
    ..We sought to compare 3-year outcomes of percutaneous coronary intervention (PCI) according to recently published appropriateness criteria for PCI...
  16. doi request reprint Predictors and implications of coronary infarct artery patency at initial angiography in patients with acute myocardial infarction (from the CADILLAC and HORIZONS-AMI Trials)
    Sorin J Brener
    New York Methodist Hospital, Brooklyn, USA
    Am J Cardiol 108:918-23. 2011
    ..TIMI grade 3 flow before as well as after PCI is an independent predictor of greater 1-year survival. These data should inform future trials of ST-segment elevation myocardial infarction with respect to improvement in outcomes...
  17. ncbi request reprint The relation between extent of coronary artery disease measured by quantitative coronary angiography and changes in lipid profile: insights from trials of atherosclerosis regression
    Sorin J Brener
    Division of Cardiology, New York Methodist Hospital, Brooklyn, NY 11215, USA
    J Invasive Cardiol 20:261-5. 2008
    ..While favorable changes in atherogenic lipids are indisputably associated with improved clinical outcomes, a similar correlation with quantitative coronary angiography (QCA) parameters is more difficult to document...
  18. doi request reprint Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention
    Puja B Parikh
    Department of Medicine, Division of Cardiovascular Medicine, Stony Brook University Medical Center, Stony Brook, New York, USA
    Catheter Cardiovasc Interv 80:352-7. 2012
    ..Thus, we aimed to identify determinants of in-hospital mortality which are specific to patients with preserved renal function, moderate CKD, or end stage renal disease (ESRD) on dialysis, undergoing PCI...
  19. doi request reprint Changes in reference vessel diameter in ST-segment elevation myocardial infarction after primary percutaneous coronary intervention: implications for appropriate stent sizing
    Ecaterina Cristea
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
    Am Heart J 162:173-7. 2011
    ..We further investigated whether vessels treated with paclitaxel-eluting (PES) or bare-metal stents (BMS) behave differently with respect to RVD at follow-up...
  20. doi request reprint Frequency, mechanisms, and implications of late peri-stent contrast staining: analysis (from the HORIZONS-AMI Trial)
    Tadayuki Yakushiji
    Columbia University Medical Center, New York, NY, USA
    Am J Cardiol 111:1587-92. 2013
    ..Identification of PSS was not associated with subsequent stent thrombosis...
  21. doi request reprint Association of health insurance status with presentation and outcomes of coronary artery disease among nonelderly adults undergoing percutaneous coronary intervention
    Puja B Parikh
    Department of Medicine, Division of Cardiovascular Medicine, State University of New York, Stony Brook University Medical Center, Stony Brook, NY, USA
    Am Heart J 162:512-7. 2011
    ..The aim of this study was to determine if insurance status is associated with adverse outcomes in patients with coronary artery disease...
  22. doi request reprint Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarc
    Ajay J Kirtane
    Department of Medicine, Columbia University Medical Center, New York, New York Cardiovascular Research Foundation, New York, New York Electronic address
    Am J Cardiol 113:36-43. 2014
    ..Additional studies of strategies to decrease the occurrence of IPTEs are warranted...
  23. ncbi request reprint The impact of previous revascularization on clinical outcomes in patients undergoing primary percutaneous coronary intervention
    Travis J Bench
    Division of Cardiovascular Medicine, Stony Brook University Medical Center, Stony Brook, New York, USA
    J Invasive Cardiol 25:166-9. 2013
    ..Thus, only prior surgical - and not percutaneous - revascularization should be considered a significant risk factor in the setting of primary PCI...
  24. doi request reprint Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial
    Gregg W Stone
    Columbia University Medical Center and New York Presbyterian Hospital, New York, New York 10022, USA
    JAMA 307:1817-26. 2012
    ..Two strategies proposed to reduce distal embolization and improve outcomes after primary PCI are bolus intracoronary abciximab and manual aspiration thrombectomy...
  25. doi request reprint Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial
    Bimmer E Claessen
    Cardiovascular Research Foundation, New York, NY 10022, USA
    Eur Heart J 33:768-75. 2012
    ....
  26. doi request reprint Recurrent coronary artery thrombosis after anomalous right coronary artery re-implantation to the aorta
    Seol Young Han
    New York Methodist Hospital, Brooklyn, NY 11215 9008, USA
    Catheter Cardiovasc Interv 82:163-7. 2013
    ..Because this anomaly is rare, limited information exists on the effects of the procedure on myocardial perfusion. These findings raise the question of whether re-implantation of the anomalous artery is truly the superior approach...
  27. doi request reprint Prognostic utility of the SYNTAX score in patients with single versus multivessel disease undergoing percutaneous coronary intervention (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial)
    Adriano Caixeta
    Hospital Israelita Albert Einstein, Sao Paulo, Sao Paulo, Brazil Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York
    Am J Cardiol 113:203-10. 2014
    ..02 to 1.07; p = 0.002). In the overall study cohort, the SS was an independent predictor of MACE and death, and MVD (vs SVD) was not. In conclusion, the SS is a useful angiographic predictive tool for patients with SVD and MVD...
  28. doi request reprint Intralesional abciximab and thrombus aspiration in patients with large anterior myocardial infarction: one-year results from the INFUSE-AMI trial
    Gregg W Stone
    Columbia University Medical Center and New York Presbyterian Hospital, New York, NY
    Circ Cardiovasc Interv 6:527-34. 2013
    ..Whether intralesional abciximab administration and thrombus aspiration confer clinical benefits to patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction is controversial...
  29. ncbi request reprint The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials
    Jacqueline Saw
    Department of Medicine, Division of Cardiology, Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    J Am Coll Cardiol 48:1567-72. 2006
    ..We aimed to evaluate clinical outcomes among peripheral arterial disease (PAD) patients following percutaneous coronary intervention (PCI)...
  30. doi request reprint Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden
    Christie M Ballantyne
    Section of Atherosclerosis and Vascular Medicine, Department of Medicine, Baylor College of Medicine, and Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Tex 77030, USA
    Circulation 117:2458-66. 2008
    ..Intravascular ultrasound showed atheroma volume regression in a single coronary artery with <50% angiographic luminal narrowing...
  31. doi request reprint Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial
    Sorin J Brener
    New York Methodist Hospital, Brooklyn, USA
    Am Heart J 158:755-60. 2009
    ..The contribution angiographic vs electrocardiographic reperfusion parameters confer on prognosis is unclear...
  32. doi request reprint Long-term effect of chronic oral anticoagulation with warfarin after acute myocardial infarction
    Salman A Haq
    New York Methodist Hospital, Brooklyn, 11215, USA
    Am J Med 123:250-8. 2010
    ..It remains unclear whether additional chronic oral anticoagulation (OAC) improves outcomes. We set out to evaluate the risk and benefit of long-term OAC after myocardial infarction...
  33. ncbi request reprint Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials
    David E Kandzari
    Division of Cardiology, Department of Medicine, Duke University Medical Center and Duke Clinical Research Institute, Durham, NC 27715, USA
    Am Heart J 147:457-62. 2004
    ....
  34. doi request reprint Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial)
    A Garvey Rene
    Columbia University Medical Center, New York, New York
    Am J Cardiol 113:236-42. 2014
    ..73, 95% confidence interval 1.27 to 2.36) at 3 years. In conclusion, new-onset AF after PCI for ST-segment elevation myocardial infarction was associated with markedly higher rates of adverse events and mortality. ..
  35. doi request reprint Impact of the severity of coronary artery calcification on clinical events in patients undergoing coronary artery bypass grafting (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial)
    Konstanze Ertelt
    Cardiovascular Research Foundation, New York, New York
    Am J Cardiol 112:1730-7. 2013
    ..The presence of severe coronary calcification was identified as an independent predictor of MACE and death or MI 1 year after CABG. ..
  36. doi request reprint Impact of scheduled angiographic follow-up in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
    Catalin Mindrescu
    Cardiovascular Research Foundation, New York, New York, USA
    J Interv Cardiol 26:319-24. 2013
    ..In conclusion, SAF after primary PCI in STEMI is associated with doubling of the rate of revascularization without an improvement in death or MI, and therefore cannot be recommended...
  37. doi request reprint Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention: Insights From the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Interv
    Philippe Genereux
    Columbia University Medical Center, New York, New York Cardiovascular Research Foundation, New York, New York Hôpital du Sacré Coeur de Montréal, Universite de Montreal, Montreal, Quebec, Canada
    J Am Coll Cardiol 63:619-29. 2014
    ..This study sought to evaluate the clinical impact of intraprocedural stent thrombosis (IPST), a relatively new endpoint...
  38. doi request reprint Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery
    Michael J Domanski
    Mount Sinai Cardiovascular Institute, New York, New York 10029, USA
    JAMA 305:585-91. 2011
    ..Also, the long-term prognostic impact of small increases of perioperative enzyme has not been reported...
  39. ncbi request reprint Flow-dependent changes resulting in restoration of patency of the left internal mammary artery graft after documented atresia
    Raja Nawaz
    Department of Cardiology, New York Methodist Hospital, 476 6th Street, Brooklyn, NY 11215, USA
    J Invasive Cardiol 23:207-10. 2011
    ..We report a patient in whom the LIMA was occluded 2 years after CABG, but was found to be completely patent 5 years later, after worsening of the left anterior descending artery disease...
  40. doi request reprint Effect of gender and race on outcomes in dialysis-dependent patients undergoing percutaneous coronary intervention
    Puja B Parikh
    Department of Medicine, Division of Cardiovascular Diseases, Stony Brook University Medical Center, Stony Brook, New York, USA
    Am J Cardiol 107:1319-23. 2011
    ..Although being a black woman was an independent predictor of mortality, race per se was not an independent predictor of in-hospital mortality...
  41. doi request reprint Initial strategy of revascularization versus optimal medical therapy for improving outcomes in ischemic heart disease: a review of the literature
    A Vincent Songco
    Division of Cardiology, New York Methodist Hospital, 506 6th Street, Brooklyn, NY 11215, USA
    Curr Cardiol Rep 14:397-407. 2012
    ....
  42. doi request reprint Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study
    Sorin J Brener
    Cleveland Clinic Foundation, Cleveland, OH, USA
    Eur Heart J 29:1127-35. 2008
    ....
  43. doi request reprint Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients
    Sorin J Brener
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA
    Am J Cardiol 101:169-72. 2008
    ..Diabetes mellitus and advanced co-morbidity were the principal determinants of survival. These findings support the need for randomized trials with adequate follow-up to compare the 2 approaches...
  44. ncbi request reprint Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial
    Sorin J Brener
    Cleveland Clinic Foundation, Cleveland, Ohio, USA
    J Am Coll Cardiol 39:377-86. 2002
    ..This study was designed to test the hypothesis that eptifibatide and reduced-dose tissue plasminogen activator (t-PA) will enhance infarct artery patency at 60 min in patients with acute myocardial infarction (AMI)...
  45. ncbi request reprint Real-world bare metal stenting: identification of patients at low or very low risk of 9-month coronary revascularization
    Stephen G Ellis
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Catheter Cardiovasc Interv 63:135-40. 2004
    ..Conversely, if the benefits of DESs are attenuated in routine practice, many groups of patients treated with BMSs may have nearly comparable results...
  46. ncbi request reprint Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report
    Sorin J Brener
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 44195, USA
    Am Heart J 155:140-6. 2008
    ..Although an early invasive strategy improves outcome in these patients, there are limited data on culprit-only, single-vessel (SV) percutaneous coronary intervention (PCI) or MV PCI in the NSTE ACS setting...
  47. ncbi request reprint Efficacy and safety of multivessel percutaneous revascularization and tirofiban therapy in patients with acute coronary syndromes
    Sorin J Brener
    Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Cardiol 90:631-3. 2002
  48. ncbi request reprint A randomized multicenter trial comparing a new, low-pressure versus a conventional coronary stent: primary results from the CONSERVE trial
    Sorin J Brener
    The Cleveland Clinic Foundation, OH 44195, USA
    J Invasive Cardiol 15:128-32. 2003
    ..02). Thus, the new LP stent achieves rates of revascularization that are not inferior to the Guidant stent, but this effect cannot be linked to lower-pressure deployment...
  49. ncbi request reprint Antihypertensive therapy and regression of coronary artery disease: insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular So
    Sorin J Brener
    Department of Cardiovascular Medicine and Biostatistics, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Am Heart J 152:1059-63. 2006
    ..We set out to explore the relationship between quantitative coronary angiography parameters, baseline characteristics, and clinical events in a large trial of CAD regression with antihypertensive agents...
  50. ncbi request reprint Effect of uncoated stenting versus balloon angioplasty alone of long coronary (>20 mm) versus shorter narrowings on one-year event-free survival
    Fernando A Cura
    Department of Cardiology, Instituto Cardiovascular de Buenos Aires, Argentina
    Am J Cardiol 91:587-90. 2003
  51. ncbi request reprint Revisiting optimal anticoagulation with unfractionated heparin during coronary stent implantation
    Sorin J Brener
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Cardiol 92:1468-71. 2003
    ..3%, 7.5%, 8.1%, and 7.1%, respectively (p=0.71). The incidence of bleeding complications was 6.6%, 5.9%, 6.9%, and 7.3%, respectively (p=0.81). ACT did not independently predict either ischemic or hemorrhagic complications...
  52. ncbi request reprint Relation of myocardial perfusion to mortality after primary percutaneous coronary intervention
    Juhana Karha
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Cardiol 95:980-2. 2005
    ..This observation has important implications for the methods of evaluating primary PCI results and the strategies used to improve myocardial reperfusion...